RxDoctor Payments Data

Douglas Roese, MD

Vascular Surgery · Columbus, INNPI 1699889162

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,347 of the $3,802 with a category attached, or 61.7%. 24 manufacturers reported payments, led by Cardiovascular Systems Inc. at 36.7% of the total. Reporting peaked in 2022 at $1,545 and has fallen 83.0% since, to $262 in 2025. That places this record below the midpoint for vascular surgery clinicians in IN, where the typical reported total is $4,328.

$3,802in general payments, 2019–2025

Across 66 payments — averaging $57.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cardiovascular Systems Inc.$1K
  • Philips North America LLC$603
  • Inari Medical, Inc.$365
  • Abbott$238
  • Terumo Medical Corporation$226
  • Boston Scientific$155
  • plus $820 from 18 others

What the payments were for

  • Travel & lodging$1,45538%
  • Food & beverage$2,34762%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,802 in reported general payments places this provider in the 45th percentile of 71 vascular surgery providers in Indiana.

See all vascular surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$261,631
Medicare patients
314
Services billed
1,203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate151$901
Cilostazol18$337
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$226
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$100
Mupirocin14$100

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Columbus

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →